Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension

It is widely accepted that impaired bioavailability of endothelial nitric oxide (NO) plays a critical role in the pathophysiology of pulmonary arterial hypertension (PAH). However, there are published data that show that relatively many PAH patients respond favorably to acetylcholine‐induced pulmona...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Physiol Rep
Autors principals: Tanaka, Mariko, Abe, Kohtaro, Oka, Masahiko, Saku, Keita, Yoshida, Keimei, Ishikawa, Tomohito, McMurtry, Ivan F., Sunagawa, Kenji, Hoka, Sumio, Tsutsui, Hiroyuki
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727286/
https://ncbi.nlm.nih.gov/pubmed/29208691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13537
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars